Vontobel Holding
RGNX icon

Vontobel Holding’s Regenxbio RGNX Stock Holding History

Vontobel Holding’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-46,639
Closed -$1.23M – 1117
2022
Q3 		$1.23M Sell
46,639
-2,668
-5% -$79.2K 0.01% 500
2022
Q2 		$1.22M Buy
+49,307
New +$1.23M 0.01% 496
2021
Q4 		– Sell
-10,000
Closed -$419K – 1188
2021
Q3 		$419K Hold
10,000
– – ﹤0.01% 851
2021
Q2 		$389K Hold
10,000
– – ﹤0.01% 837
2021
Q1 		$341K Hold
10,000
– – ﹤0.01% 763
2020
Q4 		$454K Buy
+10,000
New +$349K ﹤0.01% 678

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return